Kancare Pharmaceuticals Private Limited
About Kancare Pharmaceuticals Private Limited
Data last updated:
Kancare Pharmaceuticals Private Limited is a private limited company based in Roorkee, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24299UR2019PTC009529. Its GSTIN is 05AAHCK5035F1ZS (Uttarakhand).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Preeti Paliwal and Mayank Kumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Khasra No. 396 Vill.Nanheda Anantpur Pargana Bhagwanpur, Roorkee, Uttarakhand, India – 247667.
As per the financials filed for FY 2023, the company reported a revenue of ₹65.29 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹67.38 Lakh (net margin -103.2%) and EBITDA of -₹61.99 Lakh (EBITDA margin -94.9%). Revenue has declined at a compounded annual rate (CAGR) of 48% over three years.
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹80 Lakh on record. Court records list 5 cases involving the company, including 5 filed against it; 5 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kancare Pharmaceuticals Private Limited's registered office is in Roorkee, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKhasra No. 396 Vill.Nanheda Anantpur Pargana Bhagwanpur, Roorkee, Uttarakhand, India – 247667
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kancare Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kancare Pharmaceuticals Private Limited
FY 2023 filings availableKancare Pharmaceuticals Private Limited reported revenue of ₹65.29 Lakh (up 1596% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 48% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹61.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹67.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -94.9% | ||||
| Net Profit Margin | -103.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kancare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kancare Pharmaceuticals Private Limited
Kancare Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Paliwal | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
| Mayank Kumar | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
| Shobha Tyagi | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Kancare Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Germex Pharmaceuticals Private Limited | ₹65.75 Lakh (FY 2024) | 36.0% | New Delhi, Delhi, India | |||
| Calsita Futuristic Private Limited | ₹65.57 Lakh (FY 2025) | 91.0% | Vadodara, Gujarat, India | |||
| Nunchi Pharma Private Limited | ₹65.56 Lakh (FY 2025) | 3.0% | Delhi, India | |||
| Akquamed Pharmaceuticals Private Limited | ₹65.5 Lakh (FY 2024) | -32.0% | Lucknow, Uttar Pradesh, India | |||
| Noventia Pharmaceuticals Private Limited | ₹65.33 Lakh (FY 2024) | 15.0% | Pune, Maharashtra, India | |||
| Kancare Pharmaceuticals Private Limitedthis company | ₹65.29 Lakh (FY 2023) | -₹67.38 Lakh | -103.2% | 1596.0% | 13 | Roorkee, Uttarakhand, India |
| Victro Pharmaceuticals Private Limited | ₹65.24 Lakh (FY 2025) | -30.0% | New Delhi, Delhi, India | |||
| Hindustan Pharmatech Private Limited | ₹65.21 Lakh (FY 2025) | -34.0% | Mumbai, Maharashtra, India | |||
| Akon Pharmaceuticals Private Limited | ₹65.2 Lakh (FY 2024) | 196.0% | Surat, Gujarat, India | |||
| Zecon Pharmaceuticals Private Limited | ₹65.17 Lakh (FY 2024) | -77.0% | Lucknow, Uttar Pradesh, India | |||
| Kamalsons Pharma Private Limited | ₹65.17 Lakh (FY 2025) | 1019.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Kancare Pharmaceuticals Private Limited, buy the company report.
Auditor
Kancare Pharmaceuticals Private Limited is audited by MOHIT ARORA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHIT ARORA & CO | FY 2019 | 011741C |
Shareholding
The shareholding of Kancare Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Kancare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jul 2020 | 100351114 | Others | ₹80 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Kancare Pharmaceuticals Private Limited has 5 court cases on record: 5 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 5 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Krishna, Andhra Pradesh | Court case (PRC) | Filed against the company by an individual | Pending |
| District court, Guntur, Andhra Pradesh | Court case (PRC) | Filed against the company by Andhra Pradesh State, Drugs Inspector, Zone-1, Guntur | Pending |
| District court, Guntur, Andhra Pradesh | Court case (PRC) | Filed against the company by an individual | Pending |
| District court, West Godavari, Andhra Pradesh | Court case (PRC) | Filed against the company by an individual | Pending |
| District court, East Godavari, Andhra Pradesh | Court case (PRC) | Filed against the company by Andhra Pradesh State Rep by the Drugs Inspector, Rajamahendravaram Urban | Pending |
To see the full case history of Kancare Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kancare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kancare Pharmaceuticals Private Limited has a workforce of 13 employees on its EPFO records as of Oct 2020, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2020-21 | 13 |
| FY 2019-20 |
To see the full employee and EPFO history of Kancare Pharmaceuticals Private Limited, buy the company report.
GST
Kancare Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAHCK5035F1ZS | Uttarakhand | Active | 19 Feb 2019 |
To see the full GST registrations and return filing status of Kancare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kancare Pharmaceuticals Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Mohd Tahseen ceased to be Director on 21 Sep 2019.
Frequently asked questions
Kancare Pharmaceuticals is an active private limited company based in Roorkee, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 February 2019 (7+ years old) and is registered under CIN U24299UR2019PTC009529.
Kancare Pharmaceuticals has 3 current directors:
- Preeti Paliwal - Director
- Mayank Kumar - Director
- Shobha Tyagi - Director
The latest financial statements of Kancare Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Kancare Pharmaceuticals is 05AAHCK5035F1ZS, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Kancare Pharmaceuticals is U24299UR2019PTC009529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kancare Pharmaceuticals has 5 court cases on record: 5 filed against it. 5 are pending.
Kancare Pharmaceuticals was incorporated on 15 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Kancare Pharmaceuticals by revenue are Germex Pharmaceuticals Private Limited, Calsita Futuristic Private Limited, Nunchi Pharma Private Limited, Akquamed Pharmaceuticals Private Limited, Noventia Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Mohd Tahseen ceased to be Director on 21 Sep 2019. Mayank Kumar was appointed as Director on 15 Feb 2019. Preeti Paliwal was appointed as Director on 15 Feb 2019. Kancare Pharmaceuticals has 4 board changes on record in total.
The registered office of Kancare Pharmaceuticals is at Khasra No. 396 Vill.Nanheda Anantpur Pargana Bhagwanpur, Roorkee, Uttarakhand, India – 247667.
Kancare Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
